Correspondence 0001193125-23-246933 from Renalytix plc (RNLX, RTNXF) (CIK 0001811115) (RENXF)
Renalytix plc (RNLX, RTNXF) (CIK 0001811115)
Date: Sept. 29, 2023 · CIK: 0001811115 · Accession: 0001193125-23-246933
AI Filing Summary & Sentiment
File numbers found in text: 333-274733
Letter
VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Registration Statement on Form S-3; File No. 333-274733 Acceleration Request Requested Date: Friday, September 29, 2023 Requested Time: 4:00 p.m. Eastern Time
Re: Renalytix plc
Dear Sir or Madam:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-274733) (the “Registration Statement”) to become effective on Friday, September 29, 2023, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”).
Once the Registration Statement has been declared effective, please orally confirm that event with Katie Kazem of Cooley LLP, counsel to the Registrant.
Very truly yours,
RENALYTIX PLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP September 29, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Re: Renalytix plc Registration Statement on Form S-3; File No. 333-274733 Acceleration Request Requested Date: Friday, September 29, 2023 Requested Time: 4:00 p.m. Eastern Time Dear Sir or Madam: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-274733) (the “Registration Statement”) to become effective on Friday, September 29, 2023, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”). Once the Registration Statement has been declared effective, please orally confirm that event with Katie Kazem of Cooley LLP, counsel to the Registrant. Very truly yours, RENALYTIX PLC By: /s/ James McCullough James McCullough Chief Executive Officer